Kiniksa reveals no exposure to Silicon Valley Bank; no deposits or securities held

Kiniksa Pharmaceuticals International, plc

Kiniksa confirmed it did not hold cash deposits or securities with SVB.
Company also stated it has no business relationship with SVB.
Disclosure made on March 10, 2023, amid SVB liquidity crisis.
This voluntary FD disclosure reassures investors of zero SVB exposure.

item 7.01

Kiniksa Pharmaceuticals International, plc filing history →

Source: SEC EDGAR

accession 0001104659-23-031371

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.